Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel,acetylsalicylic acid, Date of authorisation: 14/03/2010, Revision: 31, Status: Authorised
EMA confirms its recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2024-2025
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 July 2024
EMEA-001984-PIP02-20-M01
EMEA-001949-PIP02-18-M03
Senvelgo
Training session for patients, consumers and healthcare professionals involved in medicine regulatory activities, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 December 2024, 14:00 (CET) to 13 December 2024, 12:00 (CET)
EMEA-001949-PIP01-16-M05
Opinion/decision on a Paediatric investigation plan (PIP): Ultomiris, ravulizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology;Uro-nephrology, PIP number: P/0128/2023
Opinion/decision on a Paediatric investigation plan (PIP): Dovato, lamivudine,dolutegravir, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0121/2023